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Abstract
The formation of mature cells by blood stem cells is very well understood at the cellular level and we know many of the key
transcription factors that control fate decisions. However, many upstream signalling and downstream effector processes are
only partially understood. Genome wide association studies (GWAS) have been particularly useful in providing new
directions to dissect these pathways. A GWAS meta-analysis identified 68 genetic loci controlling platelet size and number.
Only a quarter of those genes, however, are known regulators of hematopoiesis. To determine function of the remaining
genes we performed a medium-throughput genetic screen in zebrafish using antisense morpholino oligonucleotides (MOs)
to knock down protein expression, followed by histological analysis of selected genes using a wide panel of different
hematopoietic markers. The information generated by the initial knockdown was used to profile phenotypes and to
position candidate genes hierarchically in hematopoiesis. Further analysis of brd3a revealed its essential role in
differentiation but not maintenance and survival of thrombocytes. Using the from-GWAS-to-function strategy we have not
only identified a series of genes that represent novel regulators of thrombopoiesis and hematopoiesis, but this work also
represents, to our knowledge, the first example of a functional genetic screening strategy that is a critical step toward
obtaining biologically relevant functional data from GWA study for blood cell traits.
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Introduction
Erythrocytes and platelets (thrombocytes in zebrafish) are the
most abundant cells in blood. In an individual, the number and
volume of both erythrocytes and platelets are highly heritable and
tightly regulated within narrow ranges, but there is a wide
variation of these parameters in the population [1,2]. The 80%
heritability of blood cell indices provided the foundation for our
recently completed GWAS meta-analysis in ,68,000 healthy
individuals for both cell types. We identified 68 genetic loci that
control the mass (volume x count) of platelets [3] and another 75
for red cell indices [4]. About a quarter of the genes proximal to
the platelet GWAS association single nucleotide polymorphisms
(SNPs) encode well studied and generally pivotal regulators of
hematopoiesis but the function of the remaining ones is unknown,
demonstrating the power of GWAS to identify novel regulators of
hematopoiesis. We have recently reported functional validation of
six genes in which the sentinel SNP was localized within a gene
and silenced ak3, rnf145, arhgef3, tpm1, jmjd1c and ehd3 in zebrafish
by MO injections. Profound effects on thrombopoiesis were
observed for all but ehd3 [3]. Furthermore, our detailed studies of
the arhgef3 gene, which encodes one of the ,70 Rho guanine
nucleotide exchange factors, showed its important role in iron
uptake and transferrin receptor internalisation in erythrocytes [5].
Based on these preliminary data, we hypothesized that the
majority of genes identified in our recent genomics efforts are
important and rate-limiting regulators of hematopoiesis and
therefore worthwhile of further investigation.
The zebrafish model has distinct advantages over other animal
models for screening large numbers of genes. Zebrafish develop-
ment occurs rapidly over the course of a few days with
thrombocytes, erythroid- and myeloid- blood cells being fully
formed and functional by 3 days post fertilisation (dpf). External
fertilisation and transparency of zebrafish embryos allow easy
visualisation of early blood-related phenotypes giving them the
advantage over mice, where development occurs in utero.
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Importantly, transcriptional mechanisms and signalling pathways
in hematopoiesis are well conserved between zebrafish and
mammals [6].
Herein, we performed a MO injection screen of 15 genes
identified in GWAS for platelet size and number to uncover novel
pathways essential in thrombopoiesis and hematopoiesis in
general. From this screen, we identified 12 new genes required
for normal hematopoiesis and ordered them on a hematopoietic
lineage tree based on their presumed function during hematopoi-
esis. Further analysis of the hematopoietic lineage tree revealed a
distinct pattern of gene distribution suggesting two main gene
clusters. One cluster of genes appears to work at the level of HSCs
affecting all derived blood cell types and the second cluster appears
to be limited to controlling the specification of the thrombocyte-
erythroid progenitors. Additionally, we show that one of the novel
candidate genes, brd3a, is essential in differentiation of thrombo-
cytes from HSCs but is dispensable for their maintenance.
Results
Gene selection
To interrogate the large number of novel hematopoietic genes
identified in the GWAS for platelet size and number we developed
an in vivo functional genomics screen in zebrafish (Figure S1). The
first step was selection of the most suitable candidate genes and
initially we selected a single gene, closest to the sentinel SNP, from
each GWAS locus [3] (Table S1). Distance from the nearest gene
was calculated as the absolute distance between SNP and
transcription start site of the gene or 39 end of last exon [3]
(Table S1). We further eliminated genes with a known function in
hematopoiesis and identified a putative zebrafish ortholog, with
over 38% identity, on the protein level, with its human
counterpart for 40 genes. Finally, we excluded all genes that
would require the use of more than two MOs, resulting in a list of
33 genes. Nearly 80% of these genes had a sentinel SNPs localized
within 10 kb. In the last step, we selected 19 genes of which 16 had
a sentinel SNP within 10 kb and three genes had a sentinel SNP
.10 kb. Five of the selected genes were duplicated in zebrafish,
resulting in a total of 24 genes to be further investigated aiming to
define their function in blood cell formation by a MO knockdown
approach in zebrafish.
We designed splice-blocking MOs for each gene and validated
their efficacy with RT-PCR and sequencing. Of the 24 MOs
tested five MOs had no effect on the target RNA and these MOs
were excluded from further analysis (Figure S2). We then assayed
the remaining 19 functional MOs for their effect on overall
development, morphology and hematopoiesis during the first
72 hours post fertilisation (hpf) and selected the optimal dose of
MO to be injected (Figure S3). Of note, based on the information
available at the ZFIN at the time and our in situ hybridization data
(Figure S4) none of the selected genes had hematopoietic specific
gene expression. For all genes, except grtp1a, the optimal dose of
MO was selected that resulted in a specific phenotype but without
gross lethality or defects in body shape or size, vasculature, heart
and circulation. We found that grtp1a MO injected embryos died
by 15 hpf even when injected with 0.8 ng of MO, thus we
excluded grtp1a from further analysis.
A reverse genetic screen identified genes essential in
hematopoiesis
Although morphological examination can detect defects with
great sensitivity, some specific defects in hematopoiesis can be
missed, and as a result information obtained from the initial
analysis might be limited. Thus, we carried out a second level of
analysis by performing in situ hybridisation with several hemato-
poietic markers, specifically, c-myb, ae1 globin, mpeg and rag1. These
were complemented with the use of the Tg(cd41:EGFP) line and
two histochemical stains, o-Dianisidine and Sudan black. The
hematopoietic markers used for phenotyping were carefully chosen
to distinguish between early and late stages of hematopoiesis as
well as thrombocytes, erythrocytes, neutrophils, macrophages and
lymphocytes (Figure S5).
We initiated screening by taking advantage of the
Tg(cd41:EGFP) reporter line, which labels thrombocytes, to
identify genes in zebrafish that, when disrupted, affect thrombo-
cyte number. We found that knock down of 15 of the 18 genes
resulted in 30–95% reduction in thrombocyte number (Figure 1,
Figure S6). Importantly, where the functional second MO was
available, the observed phenotype was comparable to the one
observed with the first MO (Figure S7, S8, Table S2).
Furthermore, concurrent knock down of p53 with gene specific
MOs did not attenuate the thrombocyte phenotype induced by
gene specific MOs, confirming that the observed decrease in the
number of thrombocytes was not induced by p53 mediated off
target effects of MO injection (Figure S9). For one of the
‘‘phenotypic’’ genes, brf1b, we have obtained the mutant through
ZMP. To test if brf1b mutants have a decreased number of
thrombocytes, the offspring were subjected to the ‘‘clotting time
assay’’ at 5 dpf [7]. Clotting time in brf1b mutant larvae was
significantly longer than in the wild type fish, suggesting a defect in
thrombopoiesis (Figure S10 A). To further confirm the specificity
of the phenotype observed in MO injected embryos and in the
absence of available mutants we performed the rescue of rcor1 MO
injected embryos using full-length zebrafish rcor1 RNA (Figure S10
B, C). We focused our further analysis on the 15 ‘‘phenotypic’’
genes and their paralogs.
To maintain the population of differentiated blood cells within
normal ranges, HSCs need to continuously maintain the balance
between self-renewal and differentiation. We reasoned that
decreased number of thrombocytes in MO injected embryos
could be the result of either reduced numbers of HSCs or altered
Author Summary
In this manuscript we report on a follow-up study of the
GWAS loci associated with the platelet size and number. A
GWAS meta-analysis identified 68 genetic loci controlling
platelet size and number. Only a quarter of those genes,
however, are known regulators of hematopoiesis. To
determine function of the remaining genes we performed
a medium-throughput genetic screen in zebrafish using
morpholinos (MOs) to knock down selected candidate
genes. Here, we report on two major findings. First we
identified 15 genes (corresponding to 12 human genes)
required for distinct stages of specification or differentia-
tion of HSCs in zebrafish. A detailed review of databases
and literature revealed limited knowledge about the
functional role of Satb1, Rcor1 and Brd3 in hematopoiesis
and for the remaining nine genes our work represents the
first study on their putative role in hematopoiesis. And
secondly, we demonstrate that brd3a is critical for
establishing, but not maintaining thrombopoietic com-
partment. Importantly, our study introduces zebrafish as a
model system for functional follow-up of GWAS loci and
generates a valuable resource for prioritization of platelet
size and number associated genes for future in-depth
mechanistic analyses. Following this route of investigation
new regulatory molecules of hematopoiesis will be added
to critical pathways.
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HSC differentiation. To assess which stage of hematopoiesis was
affected in each MO injected embryo, we performed in situ
hybridization at 3 dpf and looked for alterations in expression of
definitive hematopoiesis marker c-myb (Figure 2). Although more
than half of the MOs tested had no effect on the number of HSCs,
depletion of rcor1 resulted in an increased number of HSCs and
depletion of kalrn (1 and 2), mfn2, pdia5, psmd13 and wasplb resulted
in decreased numbers of HSCs in caudal hematopoietic tissue
(CHT) at 3 dpf. This reduction in the number of HSCs was not
evident at 30 hpf in kalrn1, mfn2, pdia5, psmd13 and wasplb MO
injected embryos (Figure S11) suggesting that the number of HSCs
at 3 dpf was most probably adversely affected by either their
homing to or survival/proliferation in CHT. However, kalrn2 and
rcor1 depleted embryos had a marked decrease in the number of
HSCs at 30 hpf, implying the important role of these genes in
specification of HSCs in the aorta-gonad-mesonephros (AGM)
(Figure S11). Importantly, analysis of vascular development by
injecting candidate gene MOs into Tg(fli1:EGFP) embryos, which
express EGFP in endothelial cells, demonstrated no major
abnormalities in vascular morphogenesis or remodeling that
would preclude circulation, indicating that the hematopoietic
defects were not secondary to a vascular phenotype (Figure S12).
Thus, our screen effectively defined a set of nine genes required for
differentiation of HSCs to thrombocytes and possibly other blood
lineages.
Hematopoiesis is often depicted by a hierarchical differentiation
tree, with HSCs at the root and the mature blood cells as the
branches. One of the intermediate cellular states is the common
myeloid progenitor (CMP), which can proliferate and differentiate
into megakaryocyte-erythrocyte progenitors (MEP) and granulo-
cyte-monocyte (GM) progenitors, which further give rise to
megakaryocytes, erythrocytes, granulocytes, monocytes and other
cell types. To investigate lineage-specific effects of the candidate
genes, we assessed the status of definitive erythropoiesis in MO
injected embryos at 4 dpf. As ae1-globin RNA was reported to be
expressed in definitive erythrocytes at 4 dpf [8], a detailed analysis
of the expression pattern of ae1-globin transcript was exploited to
reveal the initiation of definitive erythropoiesis after gene silencing.
Profound effects on definitive erythropoiesis were observed for all
but brd3a, brf1b, waspla and wdr66 (Figure S13). However, silencing
of brf1a and wasplb resulted in diminished definitive erythropoiesis,
reflecting functional divergence of duplicated genes (brf1 and waspl)
(Figure S13). Furthermore, an extensive analysis of hemoglobin
levels in primitive erythroid cells at 2 dpf showed that, with the
Figure 1. In vivo morpholino screen in zebrafish identifies 15 new regulators of thrombopoiesis. MOs were injected into one-cell stage
transgenic Tg(cd41:EGFP) zebrafish embryos and assayed for their effect on the number of thrombocytes (cd41high) at 3 dpf. Representative confocal
images were taken of the CHT. For akap10, brd3a, brf1b, kalrn 1, kalrn 2, kif1b, mfn2, pdia5, psmd13 and satb1 a severe decrease in the number of
cd41high positive cells was observed. brf1a, rcor1, waspla, wasplb and wdr66 depletion resulted in a mild phenotype, and fen1, grtp1b and tmcc2 MO
injected embryos showed no phenotype. All embryos are oriented with anterior to the left and dorsal to the top. White arrow – thrombocytes; white
arrowhead – HSCs.
doi:10.1371/journal.pgen.1004450.g001
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exception of brd3a, kalrn2 and kif1b, primitive erythropoiesis was
largely unaffected following MO knock down of candidate genes
(Figure S14). These results are consistent with the notion that the
majority of candidate genes are dispensable for specification and
differentiation of primitive erythrocytes and that fundamentally
different molecular mechanisms regulate primitive and definitive
erythropoiesis.
To establish the role of candidate genes in differentiation of the
myeloid lineage, that is neutrophils and macrophages, we
performed Sudan Black staining (for neutrophils) and in situ
hybridization using mpeg riboprobe (for macrophages) in control
and candidate gene depleted zebrafish embryos at 3 dpf. Out of 15
genes tested, depletion of nine resulted in reduced numbers of
Sudan Black positive cells and two (kif1b, waspla) had an effect on
the number of macrophages (Figures S15, S16, and S18).
Reduction in the number of Sudan Black positive cells could
reflect the absence of granules rather than neutrophils. We have,
therefore, performed in situ hybridization using mpx riboprobe for
all genes for which the knockdown resulted in a decrease in the
number of Sudan Black positive cells. For all the tested genes the
observed phenotype was comparable to the one we reported
following Sudan Black staining (Figure S17).
Finally, we analyzed the impact of loss of candidate gene
function on lymphoid development. Differentiated thymic T-cells
are exclusively derived from definitive HSCs and can be readily
identified by rag1 expression when examined at 4 dpf (Figure S19).
Not surprisingly, a significant decrease in rag1 staining was mostly
observed in the same set of genes in which we observed a decrease
in c-myb staining (a marker for HSCs), namely kalrn1, kalrn2, mfn2,
pdia5 and psmd13. In addition, injection of akap10 MO and rcor1
MO, which had no negative impact on the number of c-myb
positive cells, resulted in a significant decrease in the number of T
lymphocytes.
Analysis of expression patterns for phenotype
classification
The large number of genes analyzed and the resultant volume
of data acquired can present challenge in understanding and
interpreting the results. Hence, we used the information gained
from the initial MO knockdown screen to generate a heat-map of
phenotype profiles (Figure 3) and cluster genes with similar
phenotypic profiles. We then hierarchically positioned candidate
genes on the hematopoietic lineage tree and assigned each of them
a potential role during hematopoietic differentiation (Figure 4).
Our analysis of the hematopoietic lineage tree revealed a
distinct pattern of gene distribution, suggesting two main gene
clusters. The first cluster represents a set of genes, namely kalrn1
and -2, mfn2, pdia5, psmd13, rcor1 and wasplb, which upon depletion
affect the number of HSCs. The second major cluster represents a
set of genes, namely akap10, brf1a, kif1b, satb1 and wasplb, which
appear to be essential further down the hematopoietic tree and
affect differentiation of both definitive erythrocytes and thrombo-
cytes. These genes have presumed role in HSC fate decisions prior
to specification of the thrombocyte and erythrocyte progenitors.
Although the frequency of blood defects observed in our screen
was high, the screen was not as well suited for the identification of
knockdown phenotypes that result in subtle differences in myeloid
lineage cell production or skewing of myeloid lineage differenti-
ation. This is mainly because changes in the number of neutrophils
and macrophages arising from HSCs may be undetectable using
Figure 2. Characterization of HSCs in candidate gene depleted embryos. To assess the stage at which hematopoiesis of each MO injected
embryo was defective, we performed whole mount in situ hybridization using a c-myb probe at 3 dpf. Although more than half of MOs had no effect
on the number of HSCs, depletion of rcor1 resulted in increased numbers of HSCs and depletion of kalrn1, kalrn2, mfn2, pdia5, psmd13 and wasplb
resulted in decreased numbers of HSCs in CHT at 3 dpf. Representative images of CHT region are shown. All embryos are oriented with anterior to the
left and dorsal to the top.
doi:10.1371/journal.pgen.1004450.g002
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markers and the developmental time point outlined here. Previous
studies have shown that erythroid-myeloid progenitor cells (EMPs)
are capable of generating both macrophages and neutrophils and
that these blood cells appear in mib zebrafish despite the absence of
HSCs [9]. However, even with these caveats, we believe the
screening procedure used has proven effective for extracting
functional information from a GWAS dataset in a medium-
throughput manner.
brd3a is a rate limiting regulator of thrombopoiesis
To gain an additional insight into mechanisms by which these
newly discovered genes affect thrombopoiesis, we performed a
more extensive analysis of the function of brd3a in hematopoiesis.
The bromodomain and extra terminal domain (BET) family of
proteins, including BRD2, BRD3, and BRD4, are evolutionally
conserved and play a key role in many cellular processes by
controlling the assembly of histone acetylation-dependent chro-
matin complexes [10]. To further confirm that the defects
observed in the brd3a depleted embryos resulted from loss of
brd3a, in vitro–transcribed RNA encoding human BRD3 (hBRD3)
was injected into 1-cell stage embryos. Live confocal imaging of
zebrafish embryos injected with hBRD3-GFP confirmed that
hBRD3 binds to mitotic chromosomes (Figure 5A), a feature
previously reported for BET family proteins i.e. BRD2, BRD3 and
BRD4 [11–13]. Expression of hBRD3 in brd3a MO injected
embryos resulted in partial but statistically significant rescue of the
number of thrombocytes demonstrating that brd3a MO used in
this study exerted a specific effect (Figure 5B, C).
brd3a is essential for differentiation and not maintenance
of thrombocytes
Morpholinos do not allow gene-specific perturbation to be
carried out with temporal resolution, which is a disadvantage
when dissecting the precise role of a selected gene in hematopoi-
esis. A number of studies reported that compounds targeting BET
proteins might be used to manipulate hematopoietic development
for exploratory or therapeutic purposes [14–16]. The BET family
inhibitor, thieno-triazolo-1,4-diazepine ((+)-JQ1 in short) is a
potent, highly specific inhibitor which displaces BET proteins from
chromatin by competitively binding to the acetyl-lysine recogni-
tion pocket of BET bromodomains [17,18]. Thus, we evaluated
the pharmacological impact of (+)-JQ1 on zebrafish development
and thrombopoiesis. Exposure of zebrafish embryos to (+)-JQ1
disrupted the chromatin occupancy of hBRD3-GFP confirming the
efficacy of the inhibitor (Figure S20 A–C).
We next incubated embryos from 6 hpf in various concentra-
tions of (+)-JQ1 and (2)-JQ1 (stereoisomer which has no
appreciable affinity to BET bromodomains) [17] as a control
(Figure S21). Exposure of zebrafish embryos to 1 mg/ml (+)-JQ1
resulted in complete mortality by 24 hpf whereas the (2)-JQ1
Figure 3. Heat map summarising hematopoietic phenotypes of knock-down of 19 candidate genes. Data obtained from the initial
knock-down were used to generate a heat map of phenotype profiles. Each colored cell in the heat map shows the severity of the observed
phenotype relative to control. The most severe decrease in the number of cells is displayed in red, a moderate reduction is displayed in orange and
green denotes a cell number comparable to control. A moderate increase in the cell number is displayed in blue and grey indicates that the test was
not performed.
doi:10.1371/journal.pgen.1004450.g003
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enantiomer showed no observable effect on embryo development
(Figure S21). This early embryonic death of zebrafish embryos was
not surprising considering that knockout of Brd2 or Brd4 in mice
results in embryonic lethality, indicating an important role of these
two proteins in embryonic development [19,20]. When treated,
however, with (+)-JQ1 from 24 hpf, embryos exhibited overall
normal development even at the higher concentration (1 mg/ml) of
(+)-JQ1 (Figure S21). Although morphologically normal, throm-
bopoiesis was completely abolished in these embryos (Figure 6 A).
Interestingly, the decrease in the number of thrombocytes
appeared more prominent in the presence of (+)-JQ1 inhibitor
compared to brd3a MO knock down. This opened the possibility
that other members of the BET family might be contributing to
the observed phenotype. To investigate this further, we performed
MO knock down of zebrafish brd2a, brd2b and brd4 and assessed
the number of thrombocytes at 3 dpf. Single MO knock down of
all three genes resulted in a severe decrease in the number of
thrombocytes. These data strongly suggested that, indeed, other
members of BET family of proteins (i.e. brd2 and brd4) play an
important role in thrombopoiesis (Figure S22 A–C).
Both MO knock down and treatment with (+)-JQ1 inhibitor
from 24 hpf resulted in a severe reduction in the number of
thrombocytes at 3 dpf, suggesting an essential role for brd3a in the
differentiation of thrombocytes as opposed to a requirement for
their maintenance and survival. To address this question we
incubated Tg(cd41:EGFP) embryos with (+)-JQ1 inhibitor starting
from 3 dpf, when there is already a considerable number of
thrombocytes in CHT, and assessed their number 24 hours later,
at 4 dpf. We found that in untreated and (2)-JQ1 treated embryos
the number of thrombocytes markedly increased between 3 and
4 dpf. However, in (+)-JQ1 treated embryos we observed no
change in the number of thrombocytes (Figure 6C). Moreover we
found that (+)-JQ1 had no adverse effect on the number of HSCs
during this 24 h period of treatment (Figure 6D). Taken together
this strongly suggests that brd3a is important in differentiation of
thrombocytes from HSCs, however, once differentiated, brd3a was
dispensable for their maintenance and survival.
Discussion
GWAS meta-analysis of platelet size and number has been
successful in identifying SNPs associated with the mass (volume x
count) of platelets. In contrast with the results of GWAS in
common diseases, more than 80% of SNPs associated with
hematological traits are localized within 10 Kb of genes providing
a sound argument to infer biologically relevant candidate genes
[3,4]. Canonical pathway analyses detected a highly significant
over-representation of ‘‘core genes’’ (the sentinel SNP is within the
gene or within 10 kb from the gene) in relevant biological
functions such as hematological disease, cancer and cell cycle [3].
Figure 4. A cartoon model of the hematopoietic tree showing the stages most likely affected by candidate gene knockdown. Based
on the heat map of phenotype profiles we have hierarchically positioned candidate genes on the hematopoietic tree and assigned them a potential
role during hematopoietic differentiation. Analysis of the hematopoietic tree identified a set of genes enriched in the HSC cluster, namely: kalrn 1 and
-2, mfn2, pdia5, psmd13, rcor1 and wasplb and another set in the thrombocyte-erythroid progenitor cell cluster, namely: akap10, brf1a, kif1b, satb1,
wasplb. MPP – multipotent progenitor cell, CMP – common myeloid progenitor, CLP – common lymphoid progenitor, MEP – thrombocyte-erythroid
progenitor, GMP – granulocyte-macrophage progenitor, L – lymphocyte, E – erythrocyte, T – thrombocyte.
doi:10.1371/journal.pgen.1004450.g004
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However, three quarters of regions proximal to the platelet GWAS
SNPs harbor unfamiliar genes or known genes not previously
implicated in hematopoiesis that merit extensive follow-up
analysis. Therefore, this study was set up to address the need for
a medium-throughput method in zebrafish to dissect the functional
roles of these assumed novel regulators of hematopoiesis.
In total, our screen identified 15 genes (corresponding to 12
human genes) required for distinct stages of specification or
differentiation of HSCs in zebrafish. A detailed review of the
content of databases and literature revealed limited knowledge
about the functional role of Satb1, Rcor1 and Brd3 [21–24] in
hematopoiesis and for the remaining nine genes our work
represents the first study on their putative role in hematopoiesis.
Importantly, our results are well in line with some of the findings
reported by others. One example is RCOR1 - lineage-restricted
deployment of RCOR1 and LSD1 cofactors, through interaction
with Gfi proteins, controls hematopoietic differentiation [23].
Knock down of rcor1 in zebrafish resulted in completely blocked
differentiation of erythroid, thrombocytic, myeloid and lymphoid
lineages. These findings strongly support the hypothesis that the
published platelet GWAS [3] enriched for functional regulators of
the hematopoiesis and further support previous assumptions that a
large proportion of the genes uncovered by the aforementioned
GWAS also have a conserved role in zebrafish.
In this study, we followed a two step screening approach: in the
first instance, we used the Tg(cd41:EGFP) line in conjunction with
a panel of hematopoietic in situ hybridization probes and
histochemical staining to create a heat map with distinct
‘‘phenotype signatures’’ of each gene knock-down. We then
positioned the candidate genes on the hematopoietic cell lineage
tree and assigned them a potential role in hematopoietic
differentiation. Interestingly, our screen revealed that, although
initially selected based on their effect on the platelet size and/or
number, none of the candidates exerted a thrombocyte specific
effect. These results should be interpreted within the context of
several major differences between the effect of the SNPs and whole
embryo MO knock down on hematological traits.
First, the majority of associated SNPs identified in platelet
GWAS are in non-transcribed regions and it is likely that the
underlying mechanism linking them to the phenotype is regula-
tory. Thus, the functional effects of SNPs are subtler compared to
the knock down of transcripts achieved by MOs in our screening.
Secondly, although GWAS provided a list of SNPs associated with
the platelet size and number, there is no evidence about the
biological processes that link the associated SNP to the phenotype.
Indeed, it has been shown that in most cases the reported SNP is
not the functional SNP itself but is in linkage disequilibrium with
the SNP overlapping a functional region [25]. Experimental
evidence shows that open chromatin profiles of megakaryocytes
and erythroblasts differ and thus cell type-restricted regions of
open chromatin could influence the penetrability of the functional
SNP [26,27] in a lineage specific manner. In contrast, MO knock
down in zebrafish is not spatially restricted and thus offers the
opportunity to determine the functional role of candidate genes in
all blood lineages.
To further verify the hematopoietic role of genes identified in
GWAS, we performed a more extensive evaluation of the effect of
brd3a on thrombopoiesis. It has been shown that BRD3 interacts
with acetylated GATA1 and stabilizes its chromatin occupancy
[21]. A pharmacologic compound, JQ1, that occupies the
Figure 5. brd3a is an important regulator of thrombopoiesis. (A) Live confocal imaging of zebrafish embryos injected with hBRD3-GFP mRNA
revealed the nuclear localization of hBRD3 and that it binds to mitotic chromosomes (white arrows). Expression of hBRD3 in brd3a MO injected
embryos resulted in a partial rescue of the number of thrombocytes as shown in (B). (C) A graph to illustrate the number of thrombocytes in control,
splice brd3a MO and splice brd3a MO plus hBRD3 mRNA injected embryos. Each dot represents the number of thrombocytes in the individual MO-
injected embryos with respect to control. A blue horizontal line represents the mean value of the number of thrombocytes for each group of
embryos. Student t test, * p = 0.016; n = 17. All embryos are oriented with anterior to the left and dorsal to the top.
doi:10.1371/journal.pgen.1004450.g005
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acetyl-lysine binding pockets of Brd3 bromodomains disrupts the
BRD3-GATA1 interaction, diminishes the chromatin occupancy
of both proteins, and inhibits erythroid maturation [21]. Although
GATA1 and BRD3 co-occupancy on GATA1 target genes was
also observed in a megakaryocytic cell line [21], the biological
relevance of this binding was never confirmed. Here we report on
the important role of brd3a in thrombopoiesis. Indeed, knock-down
of brd3a with two independent MOs as well as treatment of
zebrafish embryos with the JQ1 inhibitor starting from 24 hpf
severely reduced the number of thrombocytes in 3 days old
embryos. Interestingly, incubation of embryos with JQ1 inhibitor
between 3- and 4 dpf, that is after the onset of thrombopoiesis, did
not have any effect on the already differentiated thrombocytes.
However, the number of thrombocytes failed to increase
compared to control embryos within this 24-hour period. These
results strongly support the idea that brd3a is critical for
establishing but not maintaining thrombopoietic compartment.
Some previous studies suggest that BRD3, as well as some other
mitotically retained factors, functions as a molecular ‘‘bookmark’’
by enabling post-mitotic transcription re-initiation of its target
genes [13,28]. It is plausible to assume that a similar mechanism is
employed during thrombopoiesis. In that scenario, retention of
Brd3 on chromatin during mitosis of thrombocyte precursors or
erythroid-thrombocyte progenitor cells would contribute to the
maintenance of transcription patterns necessary for establishment
of thrombocyte identity. However, further work will be necessary
to identify the precise molecular mechanisms by which brd3a exerts
its effect on thrombopoiesis. Taken together, our study provides a
paradigm of the usefulness of zebrafish for efficient translation of
GWAS findings into relevant biological information in an
objective and unbiased manner. GWAS have mapped many
novel, convincingly associated loci in the proximity of genes where
functional significance is expected. So far, functional validation of
such genes has remained confined to single gene approaches. Here
we utilized the powerful genetics and translucency of zebrafish
larvae to undertake a medium-throughput screen of genes
implicated in human hematopoietic variation. The results of this
screen will help us to tentatively place novel genes in molecular
pathways and thus close the ever-increasing knowledge gap on the
biological function of gene candidates identified by genomic
technologies.
Materials and Methods
Ethics statement
The maintenance, embryo collection and staging of the wild
type (Tubingen Long Fin) and transgenic zebrafish lines
(Tg(cd41:GFP), Tg(fli1:GFP), Tg(c-myb:EGFP) were performed in
accordance with EU regulations on laboratory animals, as
previously described [29,30].
Figure 6. brd3a is required for differentiation and not maintenance of thrombocytes. (A) Exposure of zebrafish embryos to 1 mg/ml (+)-JQ1
from 24 hpf resulted in a severe reduction in the number of thrombocytes compared to DMSO or (2)-JQ1 treated embryos. (B) A graph to illustrate
the average number of thrombocytes at 3 dpf. Embryos were exposed to DMSO, (2)-JQ1 or (+)-JQ1 starting from 24 hpf. Each dot represents
thrombocyte count for a single embryo. Horizontal line denotes average thrombocyte number. Student t test, ** p = 1.661028, n = 17. (C) To assess
whether brd3a is essential for differentiation of thrombocytes or for their maintenance and survival we incubated Tg(cd41:EGFP) embryos in DMSO or
with (+)-JQ1 inhibitor starting from 3 dpf and checked thrombocyte number 24 hours later, at 4 dpf. We found that in untreated (DMSO) embryos
the number of thrombocytes markedly increased between 3- and 4 dpf; however, in (+)-JQ1 treated embryos there was no change in the number of
thrombocytes. In contrast, the inhibitor had no adverse effect on the number of HSCs during this 24 h period of treatment (D). Representative
confocal images of CHT region are shown. All embryos are oriented with anterior to the left and dorsal to the top.
doi:10.1371/journal.pgen.1004450.g006
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Embryo injections
Morpholinos (GeneTools, LLC) were re-suspended in sterile
water and diluted to chosen concentration. Approximately 1 nl
was injected into embryos at 1- to 2-cell stage. MOs used are
summarized in Table S2.
Plasmid with full-length human hBRD3 cDNA was purchased
from Source Bioscience (Nottingham, UK). hBRD3 was cloned
into pCS2 expression vector using gene-specific primers: AAT-
TACATCGATACCATGTCCACCGCCACGACAGT (forward)
and CCCGAGTCTAGACTATTCTGAGTCACTGCTGTCA-
GA (reverse) and AAATTAGAATTCACCATGTCCACCGC-
CACGACAGT (forward) and ATGTTAACCGGTAGTTCT-
GAGTCACTGCTGTCAGA (reverse) for cloning into the pCS2-
EGFP vector. Restriction enzyme sites (ClaI/XbaI and EcoRI/
AgeI respectively) used for cloning are underlined. Zebrafish full-
length rcor1 cDNA was cloned into pCS2 vector using gene-specific
primers: GTTATAGAATTCATGCCCGCAATGTTAGAGA-
AG (forward) and AGGCGCCTCGAGTCAGGAAACCGAA-
GGGTTCTG (reverse). Restriction enzyme sites (EcoRI and
XhoI, respectively) are underlined.
hBRD3, hBRD3-GFP and rcor1 mRNA was synthesized with
mMESSAGE mMACHINE kit (Ambion), according to the
manufacturer’s protocol. In the rescue experiment, 100 pg of
hBRD3 mRNA or 125 pg rcor1 RNA was injected into the one cell
stage control and MO-injected Tg(cd41:EGFP) embryos. In the
hBRD3 localization experiment, 300 pg of hBRD3-GFP mRNA
was injected into Tubingen Long Fin embryos at 1-cell stage.
Reverse Transcription-Polymerase Chain Reaction (RT-
PCR)
In order to verify the effectiveness of MOs in affecting their
target transcripts, RT-PCR was performed. RNA was subjected to
reverse transcription using Superscript II Reverse Transcriptase
(Invitrogen). PCR was performed using gene-specific primers
(listed in Table S2) and KOD Hot Start DNA Polymerase
(Novagen).
Whole mount in situ hybridisation
In situ hybridization was performed with riboprobes specific for
c-myb, ae1-globin, mpx, mpeg and rag1 as previously described [31], as
well as for brd3a, brf1b, kalrn1, waspla and wdr66. Primers used for
PCR amplification of candidate genes for probe synthesis are listed
in Table S3. Photomicrographs were taken with a Zeiss camera
AxioCam HRC attached to a LeicaMZ16 FA dissecting micro-
scope (Leica Microsystems, Germany) using the AxioVision
software.
O-dianisidine staining
O-dianisidine staining was performed as previously described
[32].
Sudan Black staining
Sudan Black staining was performed as previously described
[33].
Clotting time assay
Clotting time assay was performed as previously described [7].
In short, 5 dpf larvae were anaesthetized in 0.02% tricaine
solution in embryonic water and transferred onto a Petri dish in a
small drop of liquid. Caudal veins of the larvae were wounded with
the tip of a Microlance needle (0.4 mm613 mm, Becton
Dickinson) in the anal area. For each larva the time passing
between inflicting the wound and the stop of bleeding was
recorded.
Genotyping
Genomic DNA was isolated from 5 dpf larvae, which were
individually loaded into wells of a 96-well plate. Fish were
incubated in 25 ml of lysis buffer (25 mM NaOH with 0.2 mM
EDTA) at 95uC for 30 min. Afterwards 25 ml of neutralization
buffer (40 mM Tris-HCl) was added. Genotyping was carried out
using the KASP genotyping assays (KBioscience). Each reaction
consisted of 4 ml of genomic DNA and 5 ml of PCR mix, according
to the manufacturer’s protocol (KBioscience). PCR products were
analyzed using PHERAstar plus (BMGlabtech) and KlusterCaller
software (KBioscience).
Imaging
Images were captured with the use of a Leica TCS SP5 confocal
microscope with Leica LAS AF software (Leica Microsystems),
using a 406 immersion lens or with Axio Zoom.V16 fluorescent
microscope with AxioCam MRm camera using 2606magnifica-
tion.
BET protein inhibitor
Selective inhibitor of human BET family of bromodomain-
containing proteins, thieno-triazolo-1,4-diazepine, named JQ1,
was kindly provided by Dr Chas Bountra, Structural Genomics
Consortium, University of Oxford, Oxford, UK. Both the active
inhibitor, (+)-JQ1, and its inactive stereoisomer, (2)-JQ1, were
dissolved in dimethylsulfoxide (DMSO) to 10 mg/ml and stored in
aliquots at 220uC. For zebrafish embryo treatment, (+)-JQ1 and
(2)-JQ1 were diluted in egg water to desired concentration and
added to the embryos at ,6 hpf, 24 hpf or 3 dpf and afterwards
replaced daily. Control embryos were incubated in the equal
concentration of DMSO in egg water as inhibitor-treated
embryos.
Supporting Information
Figure S1 We selected genes with unknown function in
hematopoietic biology and reliable zebrafish ortholog identifica-
tion with over 38% identity at the protein level with its human
counterpart. We next designed MO against each candidate gene
and tested the efficacy of MOs by RT-PCR and sequencing,
where appropriate. For all genes, the optimal dose of MO was
selected that results in a specific phenotype but without gross
lethality and defects in body shape and size, vasculature, heart and
circulation. Finally, we performed phenotyping of MO injected
embryos using a wide panel of different hematopoietic markers.
(TIFF)
Figure S2 Splice modifications caused by gene-specific MOs
were assayed by RT-PCR, using gene-specific primers, and are
seen as a band shift after gel electrophoresis of RT-PCR products.
The binding site of MO to pre-mRNA is marked with a red
horizontal line. For each gene a schematic diagram illustrates the
effect of MOs on pre-mRNA splicing. Nucleotide sequences
denote a frame shift caused by aberrant splicing. Where no band
was obtained from the MO-injected group, RT-PCR for b-actin
was used as a control for equal loading of cDNA. i-intron; e-exon.
(TIFF)
Figure S3 In order to determine the optimal dose of the MOs to
be injected, a dose-response experiment was performed. For each
gene the concentration of MO (shown in lower right corner of
each image, in ng) was selected that elicited a specific phenotype
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without an overt non-specific effect. Knock-down of grtp1a resulted
in early embryonic lethality even when injected with 0.8 ng of
MO. Thus, grtp1a was excluded from further analysis. The optimal
MO dose for each gene as determined in this experiment was used
in all subsequent experiments.
(TIFF)
Figure S4 Whole-mount in situ hybridization using brd3a, brf1b,
waspla, kalrn1 and wdr66 riboprobes is shown. Panels show a lateral
view of embryos at 3 dpf. All embryos are oriented with anterior to
the left and dorsal to the top.
(TIFF)
Figure S5 The phenotyping was initiated by using the
Tg(cd41:EGFP) reporter line that labels thrombocytes to identify
genes in zebrafish that, when knocked down, affect thrombocyte
number. The genes for which MO knock-down did not result in a
change in number of thrombocytes were excluded from further
analysis. For the ‘‘phenotypic’’ genes, we carried out a second level
of analysis by performing whole mount in situ hybridisation for
several hematopoietic markers, namely: c-myb, ae1 globin, mpeg and
rag1, in order to assess the number of HSCs, definitive
erythrocytes, macrophages and lymphocytes, respectively. These
were complemented with the use of two histochemical stains: o-
Dianisidine, to assess the number of primitive erythrocytes at 2 dpf
and Sudan Black, to determine the number of neutrophils in CHT
at 3 dpf. Finally, if the MO knock-down resulted in a decreased
number of HSCs at 3 dpf, an additional step was introduced to
assess their number at 30 hpf in AGM. Where the MO knock-
down resulted in a decreased number of Sudan Black positive cells,
whole mount in situ hybridisation for mpx was performed.
(TIFF)
Figure S6 The number of thrombocytes (cd41bright) in the CHT
was counted for each gene knock-down. Of the 18 genes
examined, knock down of 15 resulted in a 30–95% reduction in
the number of thrombocytes. One-tailed Student t test was
performed. Significant decrease in the number of thrombocytes
was observed in: akap10 (p = 4.4761025, n = 10), brd3a
(p = 0.00021, n= 11), brf1a (p = 0.005, n= 9), brf1b
(p = 2.561027, n = 15), kalrn1 (p = 1.461026, n = 13), kalrn2
(p = 1.261029, n = 15), kif1b (p = 5.761026, n = 17), mfn2
(p = 1.4961025, n = 15), pdia5 (p = 0.00018, n= 11), psmd13
(p = 4.1261028, n = 9), rcor1 (p = 0.00042, n= 20), satb1
(p = 9.5161027, n = 15), waspla (p = 0.00157, n= 15), wasplb
(p = 0.023, n= 20) and wdr66 (p = 0.00027, n = 15) depleted
embryos. Each dot represents the number of thrombocytes in an
individual MO-injected embryo with respect to control. A blue
horizontal line represents the mean value of the number of
thrombocytes for each group of embryos.
(TIFF)
Figure S7 To verify that MOs used in this study exerted a
specific effect on hematopoiesis we designed a second non-
overlapping morpholino (MO2) for all ‘‘phenotypic’’ candidate
genes. Splice modifications caused by gene-specific MOs were
assayed by RT-PCR, using gene-specific primers, and were
confirmed for all but brf1a, kif1b and wasplb MO2. These three
MO2 were therefore excluded from further analysis. Injection of
the remaining 12 MO2 resulted in the phenotype that was
comparable to the one observed with the first MO. Representative
fluorescent images of the CHT are shown. All embryos are
oriented with anterior to the left and dorsal to the top.
(TIFF)
Figure S8 Splice modifications caused by gene-specific second
non-overlapping MOs (MO2) were assayed by RT-PCR, using
gene-specific primers, and are seen as a band shift after gel
electrophoresis of RT-PCR products. Where no band was
obtained from the MO-injected group, RT-PCR for b-actin was
used as a control for equal loading of cDNA.
(TIFF)
Figure S9 MO activities in zebrafish embryos include both
sequence-specific RNA binding as well as effects not associated
with loss of function of the targeted locus i.e. ‘‘off-target’’
effects. As p53 MO can reduce common off-target effects, the
number of thrombocytes was assessed in CHT at 3 dpf in
embryos co-injected with p53 MO and gene-specific MOs.
Concurrent knock down of p53 with gene-specific MOs did not
attenuate the thrombocyte phenotype induced by gene-specific
MOs, confirming that the observed decrease in the number of
thrombocytes was not induced by off-target effects of MOs. All
embryos are oriented with anterior to the left and dorsal to the
top.
(TIFF)
Figure S10 A) Fish heterozygous for a mutation in brf1b (allele
sa3097, ZMP) were crossed and their progeny (n= 41) was
subjected to a clotting time assay at 5 dpf. The time of clotting
after caudal vein puncture was recorded and the larvae were
genotyped. Each bar represents average clotting time in the group,
SEM is shown. One-tailed Student t test, * p = 0.042. B) A graph
to illustrate the number of thrombocytes in control (n = 33), splice
rcor1 MO (n= 28) and splice rcor1 MO plus rcor1 mRNA (n= 15)
injected embryos. Each bar represents average number of
thrombocytes in the group, SEM is shown. One-tailed Student t
test, * p = 0.024. C) Representative fluorescent images of embryos
in the rcor1 rescue experiment. All embryos are oriented with
anterior to the left and dorsal to the top.
(TIFF)
Figure S11 To assess the HSC emergence in the aorta-gonad-
mesonephros (AGM) region, we injected gene-specific MOs in
single-cell stage Tg(c-myb:GFP) transgenic embryos. For kalrn1,
mfn2, pdia5, psmd13 and wasplb MO injected embryos no difference
in the number of HSCs was observed when compared to the
control at 30 hpf. However, kalrn2 and rcor1 depleted embryos had
a marked decrease in the number of HSCs at 30 hpf, implying an
important role of these genes in specification of HSCs in the
AGM. Representative images of the AGM region are shown.
All embryos are oriented with anterior to the left and dorsal to the
top.
(TIFF)
Figure S12 In order to assess vascular development, MOs
targeting candidate genes were injected into Tg(fli1:EGFP)
embryos. Vascular morphology of the embryos was assessed at
3 dpf. No major abnormalities in vascular morphogenesis were
observed for any of the tested MOs, indicating that the
hematopoietic defects were not secondary to a vascular
phenotype. Representative images of the CHT region are shown.
All embryos are oriented with anterior to the left and dorsal to
the top.
(TIFF)
Figure S13 Whole mount in situ hybridization was performed
using a probe specific to ae1-globin at 4 dpf. As a result of candidate
gene knock down, depletion of ae1-globin staining was observed for
all genes but brd3a, brf1b, waspla and wdr66. Representative images
of CHT are shown. All embryos are oriented with anterior to the
left and dorsal to the top.
(TIFF)
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Figure S14 All the erythrocytes present in circulation of 2 dpf
zebrafish embryos derive from the primitive wave of hematopoi-
esis. In order to assess the primitive erythropoiesis, MO injected
embryos were stained with O-dianisidine at 2 dpf (arrow).
Knockdown of 12 out of 15 candidate genes, namely: akap10,
brf1a, brf1b, kalrn1, mfn2, pdia5, psmd13, rcor1, satb1, waspla, wasplb
and wdr66, resulted in no observable phenotype. Depletion of
brd3a, kalrn2 and kif1b resulted in a severe reduction in the number
of primitive erythrocytes. All the embryos are positioned anterior
up and dorsal to the back.
(TIFF)
Figure S15 Individual neutrophils may be detected with Sudan
Black staining. The number of neutrophils in MO-injected
embryos (nembryos = 15) in CHT was counted at 3 dpf. Knock-
down of akap10, brd3a, brf1b, kif1b, waspla or wasplb caused no
phenotype. A mild decrease (20–50%) in the number of
neutrophils was observed for brf1a, kalrn2, pdia5, rcor1, satb1 and
wdr66 MO injected embryos compared to control and kalrn1,
mfn2 and psmd13 MO injected embryos showed a severe (over
50%) depletion of neutrophils when compared to control.
Representative images of the CHT region at 3 dpf are shown.
All embryos are oriented with anterior to the left and dorsal to
the top.
(TIFF)
Figure S16 To identify neutrophils, Sudan Black staining was
performed at 3 dpf. The number of neutrophils in CHT was
counted in each group (nembryos = 15). One-tailed Student t test
was performed. Significant decrease in the number of neutro-
phils was observed in brf1a (p = 0.019), kalrn1 (p = 3.161029),
kalrn2 (p = 0.004), mfn2 (p = 1.461026), pdia5 (p = 0.004), psmd13
(p = 4.2610211), rcor1 (p = 0.012), satb1 (p = 0.011) and wdr66
(p = 9.261024) MO-injected embryos. Each dot represents the
number of neutrophils in an individual MO-injected embryo
with respect to control. A blue horizontal line represents the
mean value of the number of neutrophils for each group of
embryos.
(TIFF)
Figure S17 The expression of mpx in control as well as in brf1a,
kalrn1, kalrn2, mfn2, pdia5, psmd13, rcor1, satb1 and wdr66 depleted
embryos was assessed by in situ hybridization. For all genes tested
the reduced number of mpx positive cells was observed when
compared to the control. All embryos are oriented with anterior to
the left and dorsal to the top.
(TIFF)
Figure S18 In order to detect macrophages, whole mount in situ
hybridization was performed using the probe specific to mpeg1 at
3 dpf. For 13 out of 15 tested MOs (akap10, brd3a, brf1a, brf1b,
kalrn1, kalrn2, mfn2, pdia5, psmd13, rcor1, satb1, wasplb and wdr66)
there was no observable difference in the number of macrophag-
es. However, knock down of kif1b and waspla resulted in a severe
reduction in the number of macrophages in CHT at 3 dpf. All
embryos are oriented with anterior to the left and dorsal to the
top.
(TIFF)
Figure S19 Differentiated thymic T-cells could be readily
identified by rag1 expression when examined at 4 dpf. Whole
mount in situ hybridization with a rag1 riboprobe revealed a severe
decrease in the number of T lymphocytes in kalrn2, mfn2, pdia5 and
psmd13 MO injected embryos in thymi (arrow) at 4 dpf. Knock
down of akap10, kalrn1 and rcor1 caused a moderate decrease in T
lymphocyte numbers. All the embryos are positioned anterior up
and dorsal to the back.
(TIFF)
Figure S20 (+)-JQ1 is a highly specific inhibitor, which displaces
BET proteins from chromatin by competitively binding to the
acetyl-lysine recognition pocket of BET bromodomains. (A)
Treatment of zebrafish embryos with (+)-JQ1 disrupted the
chromatin occupancy of hBRD3-GFP as demonstrated by the
absence of GFP-positive mitotic chromosomes in these embryos
(0/142 GFP-positive cells) compared to 9/141 GFP-positive cells
in the DMSO control group. (B–C) To further quantify the
chromatin occupancy of hBRD3-GFP during mitosis, we selected
$15 mitotic cells, as shown by DAPI staining, and counted how
many of these cells were GFP positive in the presence of (+)-JQ1 or
DMSO (control). Whereas in (+)-JQ1 treated embryos none of the
DAPI positive mitotic chromosomes were GFP positive, in DMSO
treated embryos 11 cells were double DAPI/GFP positive. Asterisk
depicts GFP in the cytoplasm and arrow shows mitotic
chromosomes.
(TIFF)
Figure S21 To assess the effect of the inhibitor on embryo
development, dose response experiments were performed. Em-
bryos treated with 1 mg/mL (+)-JQ1 from 6 hpf died by 24 hpf.
The same concentration of the inactive enantiomer (2)-JQ1 did
not affect the development of embryos. Incubation in lower
concentration of (+)-JQ1 (0.5 mg/ml) led to aberrant development,
i.e. tail malformation and heart edema. The lowest tested dose,
0.25 mg/ml, did not affect the development of the embryos. To
avoid early embryonic lethality (+)-JQ1 inhibitor was added at
24 hpf. The embryos exhibited overall normal development even
at the higher concentration (1 mg/ml) of (+)-JQ1. Representative
images of embryo morphology are shown, taken at 24 hpf, 48 hpf
and 72 hpf. All the embryos are positioned with anterior to the left
and dorsal to the top.
(TIFF)
Figure S22 To assess the role of other BET family members in
thrombopoiesis MO knock down of brd2a, brd2b and brd4 was
performed. A) Although morphologically normal, embryos
injected with brd2a, brd2b or brd4 MOs had a severe decrease in
the number of thrombocytes at 3 dpf (B). Representative pictures
of CHT are shown. C) For splice-blocking MOs the effect of the
MOs was confirmed by RT-PCR. All the embryos are positioned
with anterior to the left and dorsal to the top.
(TIFF)
Table S1 Selection of the genes for in vivo functional screening.
(TIFF)
Table S2 Sequences of morpholinos and primers used in the
study. Morpholinos with no effect on the splicing of their target
transcript are underlined.
(TIFF)
Table S3 Primers used for PCR amplification of candidate genes
for probe synthesis.
(TIFF)
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